Blood/Immune System Cells TRIZ Cases
- Closed Bioreactor for Autologous T Cell Manufacturing
Rocking bioreactors automate media exchange and transduction to reduce labor intensity and contamination risks in cell therapy manufacturing.
- Adoptive Transfer of Primed B Cells for Hybridoma Generation
Adoptive transfer of primed B cells bypasses pre-existing antibody interference to boost specific cell counts.
- Vx-001 Vaccine Targeting Cryptic TERT Epitopes for Non-Immunogenic Tumors
Vx-001 vaccine overcomes non-immunogenic tumor resistance by using optimized cryptic TERT peptides to induce cytotoxic T lymphocyte responses.
- Immune Killer Cell Culture Using ConA Mitogens
Plant-derived mitogens stimulate NK and T cell expansion while removing zoonotic infection risks from animal proteins.
- Ex Vivo Activated T-Cell Composition for Targeted Cancer Therapy
Fixed ratio ex vivo activated lymphocytic subsets enhance targeting specificity in personalized cancer therapies.
- Cortical Organoids Mimicking Brain Oscillations
A protocol generates cortical organoids from human pluripotent stem cells that produce low-frequency electrical oscillations.
- Hematopoietic Progenitor Cell Marker Selection for CD8+ T Cell Production
Separating hematopoietic progenitor cells via specific marker profiles to produce CD4/CD8 double positive cells.
- In-Vitro Lymphoid Cell Clusters for Human Immune Response Modeling
An in-vitro cell cluster maintains functional lymphoid organization to produce antigen-specific antibodies and simulate adaptive immunity.
- Degradable 3D Matrix for Circulating Tumor Cell Recovery
Enzymatic degradation of a porous 3D matrix releases viable target cells, enabling early detection without complex diagnostic infrastructure.
- Regulatory T Cell Lineage Stability via Subset Segmentation
Enriched regulatory T cell composition with naive and central memory subsets improves lineage stability.
- Vascular Endothelial Cell Induction via Matrix Segmentation
Segmenting differentiation into stages with BMP4 and VEGF overcomes low purity and efficiency bottlenecks.
- Cell-Based Flow Cytometry Assay for Neutralizing Antibodies
A cell-based flow cytometry method detects neutralizing factors in patient fluids using receptor-expressing cells.
- Magnetic Particle NK Cell Culture Composition
Surface-bound cytokines on magnetic carriers replace K562 feeder cells to proliferate natural killer cells while eliminating immune rejection risks.
- Memory T Cell Expansion via Cytokine Optimization
Replacing IL-2 with IL-21 and IL-7 prevents terminal differentiation, sustaining expansion without sacrificing long-term survival.
- T Regulatory Cell Generation via Thymic Microenvironment Recapitulation
A method generates T regulatory cells by exposing pluripotent stem cells to thymic medullary epithelial cells.
- Avian B Cell Antibody Diversification via PI3Kα Inhibition
Suppressing PI3Kα activity in avian B cells overcomes immune tolerance barriers to generate high-affinity antibodies.
- Reprogramming Myeloid Progenitors to HLA-Matched Immune Cells
Exogenous transcription factors reverse myeloid lineage potential to generate patient-specific immune cells.
- MR1-Restricted TCRs for Broad Cancer Immunotherapy
Engineering MR1-restricted T cell receptors overcomes MHC polymorphism limits, enabling broad applicability across diverse patient populations.
- Ex Vivo Regulatory T Cell Expansion for GvHD Treatment
Expand regulatory T cells ex vivo to treat graft-versus-host disease while reducing immunosuppressant toxicity.
- GM-CSF Pig Macrophage Cell Line for Stable Pathogen Research
GM-CSF differentiates pig organ cells into self-renewing macrophages, resolving limited lifespan and donor variability in pathogen research.
- Serum-Free Stem Cell Differentiation via BMP4 and VEGF
Culturing pluripotent stem cells in serum-free medium with BMP4 and VEGF induces mesodermal differentiation without embryoid bodies.
- Hematopoietic Stem Cell NK Differentiation via GABA Pathway
GABA pathway activation directs hematopoietic stem cell differentiation to natural killer cells, resolving low genetic modification efficiency.
- Progenitor Cell Screening for Regenerative Drug Discovery
A method isolating progenitor cells to identify modulators of cell signaling pathways.
- Dendritic Cell Directed Stem Cell Differentiation
Co-culturing activated dendritic cells with stem populations to induce lineage-specific precursor expansion and differentiation.
- Artificial CAR T Cell Targets for Reproducible Activation
Replacing live target cells with synthetic particles eliminates genetic drift and handling variability to ensure reproducible CAR T cell activation.
- Multimeric Protein Complexes for Antigen-Specific B Cell Isolation
Segmented multimeric scaffolds bridge antigen and receptor binding to resolve the trade-off between isolation efficiency and process complexity.
- M-CSF Induction of Dendritic Cell Subtypes
M-CSF drives precursor differentiation into pDCs and cDCs, resolving the dependency on FL and GM-CSF for independent immune cell generation.
- T Cell iPSC Reprogramming for Antigen-Specific Production
Reprogram T cells into induced pluripotent stem cells to bypass sequencing bottlenecks and rapidly produce antigen-specific populations.
- Cytokine Cocktail for Monocyte Differentiation into Antigen-Presenting Cells
A cytokine cocktail converts patient monocytes into antigen-presenting cells using IL-10 and IFNγ receptor activators.
- Ex Vivo T Cell Expansion Using IL-7 and Antibody Co-Stimulation
IL-7 and antibody co-stimulation expand cord blood T cells while maintaining functional integrity to resolve apoptosis and imbalance issues.
- Anti-4-1BB Antibodies for CD8+ T Cell Isolation and Proliferation
Humanized anti-4-1BB antibodies isolate and proliferate antigen-specific CD8+ T cells, overcoming low recovery rates of tetramer methods.
- CD19 CAR CB-NK Cells for Relapsed Cancer Treatment
CD19-CAR+ viable cord blood NK cells treat relapsed CD19-positive and negative cancers after prior therapy failure.